Results 141 to 150 of about 7,765,653 (401)

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

A new official national regulations for complementary medicine practices in Saudi Arabia

open access: yesIntegrative Medicine Research, 2021
Tamer Aboushanab, Saad Baslom
doaj   +1 more source

6-Paradol mitigates rotenone-induced Parkinson’s disease via shutting TNFR-1/RIPK1/RIPK3/MLKL cascade and enhancement of PPARγ/PGC-1α/TFAM axis

open access: yesFuture Journal of Pharmaceutical Sciences
Background Zingiber officinale rhizomes (Ginger, Zingiberaceae) are used traditionally in treating various ailments, including neurodegenerative diseases.
Alaa Sirwi   +8 more
doaj   +1 more source

The Changing Face of Medicine: Women Doctors and the Evolution of Health Care in America [PDF]

open access: yes, 2008
[Excerpt] This book is a case study of one profession that plays a key role in the health care sector, which now represents about one seventh of the U.S. economy. It examines the most dramatic demographic change in this sector in the last century.
Boulis, Ann K, Jacobs, Jerry A
core   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

Faktor Predisposing, Enabling dan Reinforcing pada Pasien di Pengobatan Alternatif Radiesthesi Medik Metode Romo H. Loogman di Purworejo Jawa Tengah [PDF]

open access: yes, 2006
Radiesthetic medic alternative medicine becomes a choice for many people to get recovery especially after failure on modern medicine. The purpose of this research was to find out the predisposing, enabling and reinforcing factors of patients who were ...
Aji, B. (Binar), Devy, S. R. (Shrimarty)
core  

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy